Invesaro

Stocks ELOX Earnings

Earnings

Eloxx Pharmaceuticals, Inc. (ELOX) earnings

Quarterly results of Eloxx Pharmaceuticals, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when ELOX files with the SEC.

Next earnings date

Eloxx Pharmaceuticals, Inc. was expected to report around October 23, 2026; nothing is on file with the SEC yet.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) Eloxx Pharmaceuticals, Inc. reported revenue of - and a net loss of $4.5M.

Diluted earnings per share were -$0.66.

Filed with the SEC on August 11, 2026.

Net income by quarter
Q1 23: -$6.2M -$6.2M Q1 23Q2 23: -$4.3M -$4.3M Q2 23Q3 23: -$3.6M -$3.6M Q3 23Q4 23: -$2.9M -$2.9M Q4 23Q1 25: -$1.7M -$1.7M Q1 25Q2 25: -$1.9M -$1.9M Q2 25Q1 26: -$3.8M -$3.8M Q1 26Q2 26: -$4.5M -$4.5M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026---$4.5M-$0.66
Q1 FY2026March 31, 2026---$3.8M-$0.08
Q2 FY2025June 30, 2025---$1.9M-$5.45
Q1 FY2025March 31, 2025---$1.7M-$0.45
Q4 FY2023December 31, 2023---$2.9M-
Q3 FY2023September 30, 2023---$3.6M-$1.31
Q2 FY2023June 30, 2023---$4.3M-$1.96
Q1 FY2023March 31, 2023---$6.2M-$2.88

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Eloxx Pharmaceuticals, Inc.'s next earnings date?

Eloxx Pharmaceuticals, Inc. was expected to report around October 23, 2026; nothing is on file with the SEC yet.

Get an email when ELOX reports

Follow ELOX and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when ELOX files with the SEC.

Source: quarterly figures Eloxx Pharmaceuticals, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Eloxx Pharmaceuticals, Inc.